| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $83.3M | -7.7% |
| Cost of Revenue | $33.6M | -9.8% |
| R&D Expense | $208.5M | -10.2% |
| SG&A Expense | $76.6M | -13.4% |
| Operating Income | -$233.3M | +13.0% |
| Pre-tax Income | -$227.1M | +13.9% |
| Income Tax | -$152K | +0.0% |
| Net Income | -$227.1M | +13.8% |
| EPS (Basic) | -$4.59 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.5M | +66.6% |
| Short-term Investments | $177.2M | -26.4% |
| Accounts Receivable | $20.5M | -17.4% |
| Current Assets | $278.0M | -17.0% |
| Total Assets | $466.0M | -18.8% |
| Current Liabilities | $103.2M | -20.8% |
| Total Liabilities | $206.3M | -21.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$173.1M | +20.7% |
| Capital Expenditures | $2.4M | -75.5% |
| Investing Cash Flow | $103.4M | -45.8% |
| Financing Cash Flow | $92.7M | +365.1% |
| Free Cash Flow | -$175.6M | +23.1% |
| +23.8% |
| EPS (Diluted) | -$4.59 | +23.8% |
| Stockholders' Equity |
| $259.7M |
| -16.7% |